RMTINasdaqPharmaceutical PreparationsUS GAAP · USD

Rockwell Medical, Inc

Rockwell Medical, Inc. develops, manufactures, and distributes hemodialysis concentrates, dialysis kits, and related ancillary products for the renal care market. The company serves dialysis providers in the United States and selected international markets through its own manufacturing sites and distribution network.

Liikevaihto69,3milj. USD
−31,8 %v/v
Liikevoitto (EBIT)−4,7milj. USD
−871,5 %v/v
EBIT-marginaali−6,8%
−7,4 %-yks.v/v
Nettotulos−5,3milj. USD
−1 007,1 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

−50050100150milj. USD2020: 62 milj. USD2020: EBIT −28 milj. USD20202021: 62 milj. USD2021: EBIT −30 milj. USD20212022: 73 milj. USD2022: EBIT −17 milj. USD20222023: 84 milj. USD2023: EBIT −6,7 milj. USD20232024: 101 milj. USD2024: EBIT 0,61 milj. USD20242025: 69 milj. USD2025: EBIT −4,7 milj. USD202569−4,7
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Hemodialysis concentrates55 %

Liquid and dry concentrates used in the dialysis treatment process.

Dialysis kits and ancillary products15 %

Kits and supporting products used alongside dialysis treatments.

Bicarbonate products20 %

Liquid, acid, and dry bicarbonate products used in dialysis care.

Mixers and related equipment5 %

Dry acid concentrate mixers and related handling equipment.

Distribution services5 %

Transportation and delivery services for dialysis products to care sites.

Asiakkaat

Rockwell sells primarily to dialysis clinics and other renal care providers that need recurring supplies for hemodialysis treatments. Its customer base also includes hospital-based outpatient centers, skilled nursing facilities, and distributors that serve the dialysis market. The products are purchased because they are essential consumables in end-stage kidney disease treatment and must be supplied reliably and in compliance with medical quality standards.

Dialysis clinics

Buy concentrates, kits, and ancillary products for routine hemodialysis treatments.

Hospital-based outpatient centers

Purchase dialysis consumables for outpatient renal treatment programs.

Skilled nursing facilities

Use dialysis products for patients receiving treatment in long-term care settings.

Medical product distributors

Buy Rockwell products for onward distribution into dialysis care channels.

International dialysis providers

Purchase concentrates and mixers for dialysis operations outside the U.S.

Strategia

Rockwell is focused on expanding share in the hemodialysis market while broadening its product portfolio and improving pricing discipline. It also emphasizes organic growth, selective inorganic opportunities, and distribution partnerships that leverage its existing logistics network and manufacturing footprint.

Grow share in hemodialysis concentratesLyhyt aikaväli

The core business depends on recurring demand from dialysis providers.

Broaden renal care offeringsKeskipitkä aikaväli

A wider portfolio can deepen customer relationships and reduce product concentration.

Improve pricing and margin structureLyhyt aikaväli

Pricing discipline is important in a commodity-like consumables market.

Use partnerships and acquisitionsKeskipitkä aikaväli

External partnerships can expand the addressable market without building every product internally.

Maantiede

Q1/2026

Rockwell manufactures hemodialysis concentrates at facilities in Michigan, South Carolina, and Texas, and dry acid concentrate mixers in Iowa. It delivers products throughout the United States and also serves international customers, so logistics and regulatory compliance are central to the business model.

USA84 %
Other countries (US filing)16 %

Osuus liikevaihdosta, jonka yhtiö raportoi maantieteellisesti.

Riskit

Rockwell depends on a concentrated hemodialysis customer base, so volume losses or contract changes can materially affect demand. The business also faces regulatory, quality, and supply-chain risks because its products are used in critical care settings and must meet FDA, cGMP, AAMI, and ISO standards. Broader industry risks include pricing pressure, customer concentration, transportation execution, and the need to fund growth while maintaining access to capital.

Järjestetty vakavuuden mukaan
Customer concentration and contract dependenceKorkea

A small number of dialysis providers can represent a large share of demand.

Kohdistuu: Dialysis clinic and provider relationships

Regulatory and quality complianceKorkea

Products are used in patient care and are subject to FDA and manufacturing standards.

KohdistuuFDACGMPAAMIISO 13485
Capital availability and going-concern pressureKorkea

Growth, acquisitions, and working capital needs may require external funding.

Kohdistuu: Expansion and product development plans

Pricing pressure in consumablesKeskitaso

Dialysis supplies are recurring but competitively bid and price-sensitive.

Kohdistuu: Hemodialysis concentrates and related products

Logistics and delivery executionKeskitaso

The company relies on its own trucks and third-party carriers to serve clinics on time.

Kohdistuu: U.S. and international distribution network

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Sales are tied to product delivery and service fulfillment, so timing matters for quarterly results.

Vaikutus: Product shipments and distribution services

Inventory valuation

Medical consumables must be carried at recoverable value and may face obsolescence risk.

Vaikutus: Gross profit and working capital

Deferred consideration

Acquisition-related payments affect liabilities and financing cash flows.

Vaikutus: Evoqua Asset Acquisition deferred consideration

Lease and financing accounting

Manufacturing and transportation assets create recurring lease and debt-related obligations.

Vaikutus: Balance sheet leverage and cash flow presentation

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 24.9.2026